SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company. In the discovery phase SCYNEXIS offers its services primarily in the form of integrated research teams consisting of medicinal chemists, computational chemists, analytical chemists and bioanalytical scientists to work on a collaborative basis with our customers on projects from hit to candidate selection. Development phase services such as process chemistry, cGMP synthesis and bioanalytical are available on a fee for service project basis.